Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

Radiotherapy and Oncology

Volumn 48, Issue 2, 1998, Pages 115-122

  Kaanders, Johannes H A M ^a   Pop, Lucas A M ^a   Marres, Henri A M ^a   Liefers, Janine ^a   Van Den Hoogen, Franciscus J A ^a   Van Daal, Willem A J ^a   Van Der Kogel, Albert J ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Carbogen; Fractionation; Larynx carcinoma; Nicotinamide; Radiotherapy

Indexed keywords

CARBOGEN; NICOTINAMIDE; RADIOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL HYPOXIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX CARTILAGE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE; TISSUE NECROSIS; VOMITING;

ACTUARIAL ANALYSIS; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CARBON DIOXIDE; CARCINOMA; CELL DIVISION; CELL HYPOXIA; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NIACINAMIDE; OXYGEN; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; SALVAGE THERAPY; SURVIVAL RATE;

EID: 0031670159     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00043-7     Document Type: Article

References (47)

1. Ang, K.K., Trotti, A., Garden, A.S., et al. Overall time factor in postoperative radiation: results of a prospective randomized trial. Radiother. Oncol. 40 (Suppl. 1): S30, 1996.
2. Barton, M.B., Keane, T.J., Gadalla, T. and Maki, E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother. Oncol. 23: 137-143, 1992.
3. Brown, J.M. Evidence for acute hypoxic cells in mouse tumours and a possible mechanism of reoxygenation. Br. J. Radiol. 52: 650-656, 1979.
4. Chaplin, D.J., Horsman, M.R. and Trotter, M.J. The effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumour. J. Natl. Cancer Inst. 82: 672-676, 1990.
5. Chapman, J.D. Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies. Radiother. Oncol. 20 (Suppl.): 13-19, 1991.
6. Dische, S., Saunders, M.I., Barrett, A., Harvey, A., Gibson, D. and Parmar, M.K.B. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 44: 123-136, 1997.
7. Garden, A.S., Morrison, W.H., Ang, K.K. and Peters, L.J. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules. Int. J. Radiat. Oncol. Biol. Phys. 31: 493-502, 1995.
8. Gatenby, R.A., Kessler, H.B., Rosenblum, J.S., et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14: 831-838, 1988.
9. Henk, J.M. Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitizers? Int. J. Radiat. Oncol. Biol. Phys. 12: 1339-1341, 1986.
10. Henk, J.M., Kunkler, P.B. and Smith, C.W. Radiotherapy and hyperbaric oxygen in head and neck cancer. Lancet ii: 101-103, 1977.
11. Höckel, M., Schlenger, K., Mitze, M., Schäffer, U. and Vaupel, P. Hypoxia and radiation response in human tumors. Semin. Radiat. Oncol. 6: 3-9, 1996.
12. Horiot, J.C., Bontemps, P., van den Bogaert, W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother. Oncol. 44: 111-121, 1997.
13. Horsman, M.R., Chaplin, D.J. and Overgaard, J. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumour cells. Cancer Res. 50: 7430-7436, 1990.
14. Hoskin, P.J., Stratford, M.R.L., Saunders, M.I., Hall, D.W., Dennis, M.F. and Rojas, A. Administration of nicotinamide during CHART: pharmacokinetics, dose escalation, and clinical toxicity. Int. J. Radiat. Oncol. Biol. Phys. 32: 1111-1119, 1995.
15. International Commission on Radiation Units and measurements. Dose specification for reporting external beam therapy with photons and electrons. ICRU Publications, Report No. 29, Washington, DC, 1978.
16. International Union Against Cancer. TNM classification of malignant tumours. UICC, Geneva, 1992.
17. Kaanders, J.H.A.M., Pop, L.A.M., Marres, H.A.M., van der Maazen, R.W.M., van der Kogel, A.J. and van Daal, W.A.J. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity. Radiother. Oncol. 37: 190-198, 1995.
18. Kaanders, J.H.A.M., Stratford, M.R.L., Liefers, J., et al. Administration of nicotinamide during a five- to seven-week course of radiotherapy: pharmacokinetics, tolerance, and compliance. Radiother. Oncol. 43: 67-73, 1997.
19. Kaanders, J.H.A.M., van Daal, W.A.J., Hoogenraad, W.J. and van der Kogel, A.J. Accelerated fractionation radiotherapy for laryngeal cancer, acute and late toxicity. Int. J. Radiat. Oncol. Biol. Phys. 24: 497-503, 1992.
20. Kaanders, J.H.A.M. and van der Maazen, R.W.M. A convenient and reliable method for carbogen breathing in man. Radiother. Oncol. 29: 341-343, 1993.
21. Kaplan, E.L. and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53: 457-481, 1958.
22. Keane, T.J., Cummings, B.J., O'Sullivan, B., et al. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5-fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 25: 613-618, 1993.
23. Kummermehr, J., Dörr, W. and Trott, K.R. Kinetics of accelerated repopulation in normal and malignant squamous epithelia during fractionated radiotherapy. Br. J. Radiol. 24 (Suppl.): 193-199, 1992.
24. Martin, L., Lartigau, E., Weeger, P., et al. Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother. Oncol. 27: 123-130, 1993.
25. Mendenhall, W.M., Parsons, J.T., Mancuso, A.A., Stringer, S.P. and Cassisi, N.J. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck 18: 24-35, 1996.
26. Moulder, J.E. and Rockwell, S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys. 10: 695-712, 1984.
27. Nguyen, T.D., Malissard, L., Théobald, S., et al. Advanced carcinoma of the larynx: results of surgery and radiotherapy without induction chemotherapy (1980-1985): a multivariate analysis. Int. J. Radiat. Oncol. Biol. Phys. 36: 1013-1018, 1996.
28. Nordsmark, M., Overgaard, M. and Overgaard, J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41: 31-39, 1996.
29. Overgaard, J., Sand Hansen, H., Overgaard, M., et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. Radiother. Oncol. 46: 135-146, 1998.
30. Overgaard, J., Sand Hansen, H., Overgaard, M., et al. Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week - report from the DAHANCA 7 trial. Int. J. Radiat. Oncol. Biol. Phys. 39 (Suppl.): 188, 1997.
31. Overgaard, J. Importance of tumor hypoxia in radiotherapy. A metaanalysis of controlled clinical trials. Radiother. Oncol. 24 (Suppl.): S64, 1992.
32. Parsons, J.T., Mendenhall, W.M., Stringer, S.P., Cassisi, N.J. and Million, R.R. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience. Head Neck 15: 87-96, 1993.
33. Peters, L.J. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother. Oncol. 17: 177-190, 1990.
34. Rockwell, S. and Moulder, J.E. Hypoxic fractions of human tumors xenografted into mice: a review. Int. J. Radiat. Oncol. Biol. Phys. 19: 197-202, 1990.
35. Rojas, A., Hirst, V.K., Calvert, A.S. and Johns, H. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 34: 357-365, 1996.
36. Rojas, A. Radiosensitization with normobaric oxygen and carbogen. Radiother. Oncol. 20 (Suppl. 1): 65-70, 1991.
37. Rubin, P., Hanley, J., Keys, H.M., Marcial, V. and Brady, L. Carbogen breathing during radiation therapy. The Radiation Therapy Oncology Group Study. Int. J. Radiat. Oncol. Biol. Phys. 5: 1963-1970, 1979.
38. Saunders, M.I., Dische, S., Barrett, A., Harvey, A., Gibson, D. and Parmar, M.K.B. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. Lancet 350: 161-165, 1997.
39. 2) on the in vivo radiation response of a murine sarcoma. Int. J. Radiat. Oncol. Biol. Phys. 2: 903-911, 1977.
40. 3 laryngeal cancer treated with radical radiotherapy, time dose relationship: the concept of nominal standard dose and linear quadratic model. Int. J. Radiat. Oncol. Biol. Phys. 20: 1207-1214, 1991.
41. The Department of Veterans Affairs Laryngeal Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med. 324: 1685-1690, 1991.
42. Thomlinson, R.H. and Gray, L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9: 539-549, 1955.
43. 2 tension measurement in a murine fibrosarcoma. Radiat. Res. 120: 477-493, 1989.
44. Wang, C.C. Radiation therapy of laryngeal tumors: curative radiation therapy. In: Comprehensive Management of Head and Neck Tumors, Vol. 1, pp. 906-918. Editors: S.E. Thawley, W.R. Panje, J.G. Batsakis and R.D. Lindberg. WB Saunders, Philadelphia, PA, 1987.
45. Wang, C.C., Blitzer, P.H. and Suit, H.D. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 55: 2100-2104, 1985.
46. Withers, H.R., Taylor, J.M.G. and Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27: 131-146, 1988.
47. 4 glottic carcinomas. Am. J. Surg. 184: 467-472, 1984.